Michael Burke, the founder and long-time managing director of Chanelle Pharmaceuticals, has been chosen as The Irish Times Business Person of the Month for February, an award run in association with Bank of Ireland.
The veterinarian turned businessman sold the privately owned business he had established more than 40 years ago in the Co Galway town of Loughrea to British private equity group Exponent during the month for a figure understood to be about €300 million.
It is the largest manufacturer of generic medications for humans and animals in the State and a major employer in the region, with 730 staff.
Chanelle exports to 96 countries and supplies 10 of the top 12 multinationals worldwide in both human generics and animal health. Its portfolio of more than 5,400 licences is tilted almost two to one in favour of animal health.
The great Guinness shortage has lessons for Diageo
Ireland has won the corporation tax game for now, but will that last?
Corkman leading €11bn development of Battersea Power Station in London: ‘We’ve created a place to live, work and play’
Elf doors, carriage rides and boat cruises: Christmas in Ireland’s five-star hotels
Four years ago, Mr Burke finally broke into the US market, with a parasite protection product for cats and dogs, becoming one of only two European companies with a licence to export the products to the US.
Mr Burke has said he will retire from the business following the sale, which is subject to approval from the Competition and Consumer Protection Commission.
“Having dedicated my life to building Chanelle Pharma into a global company, I have decided the time is right to allow new owners to lead the company into its next phase of growth,” Mr Burke said.
- Sign up for Business push alerts and have the best news, analysis and comment delivered directly to your phone
- Find The Irish Times on WhatsApp and stay up to date
- Our Inside Business podcast is published weekly - Find the latest episode here
